Skip to main content
Log in

Cognitive function in hypertensives treated with atenolol or propranolol

  • Original Articles
  • Published:
Journal of General Internal Medicine Aims and scope Submit manuscript

Abstract

Study objective:To test reports that beta blockers, particularly lipopbilic forms, impair cognitive function and cause psychiatric disturbances.

Design:Randomized, double-blind, controlled crossover trial with eight-week treatment periods.

Patients:Sequential sample of 43 male veterans, with untreated diastolic blood pressures (DBP) between 90 and 110 mmHg, aged 35–64 years.

Interventions:Propranolol-LA, 80-mg tablets, or atenolol, 50-mg tablets, were given daily, incremented by one tablet at weekly intervals until DBP ≤90 mmHg. Hydrochlorothiazide was added, if necessary.

Main results:Repeated-measures ANOVA was performed on all cognitive tests. Cognitive test performance was not affected by beta blocker therapy in seven of nine tests and was enhanced on Trail Making Test. Performance was impaired only on Digit Cancellation. Neither Speilberger’s State Trait Anxiety Inventory nor the Beck Depression Inventory was affected by either beta blocker.

Conclusions:Atenolol or propranolol therapy does not impair cognitive function or contribute significantly to psychiatric side effects.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Solomon S, Hotchkiss E, Saravay SM, Bayer C, Ramsey P, Blum RS. Impairment of memory function by antihypertensive medication. Arch Gen Psychiat. 1983;40:1109–12.

    PubMed  CAS  Google Scholar 

  2. Lichter P, Richardson S, Wyke MA. Differential effects of atenolol and enalapril on memory during treatment for essential hypertension. Br J Clin Pharmacol. 1986;21:641–5.

    PubMed  CAS  Google Scholar 

  3. Bryan PC, Efiong DO, Stewart-Jones J, Turner P. Propranolol on tests of visual function and central nervous activity. Br J Clin Pharmacol. 1974;1:82–4.

    CAS  Google Scholar 

  4. Salem SA, McDevitt DG. Central effects of beta-adrenoreceptor antagonists. Clin Pharmacol Ther. 1982;33:52–7.

    Article  Google Scholar 

  5. Gengo FM, Huntoon L, McHugh W. Lipid-soluble and water-solubleβ-blockers: comparison of the central nervous system depressant effect. Arch Intern Med. 1987;147:39–43.

    Article  PubMed  CAS  Google Scholar 

  6. Cove-Smith JR, Kirk C. CNS-related side-effects with metoprolol and atenolol. Eur J Clin Pharmacol. 1985;28[suppl]:69–72.

    Article  PubMed  Google Scholar 

  7. Broadhurst AD. The effect of propranolol on human psychomotor performance. Aviat Space Environ Med. 1980;51:176–9.

    PubMed  CAS  Google Scholar 

  8. Landauer A, Pocock DA, Prott FW. Effects of atenolol and propranolol on human performance. Psychopharmacology. 1979;60:211–5.

    Article  PubMed  CAS  Google Scholar 

  9. Mazzucchi A, Mutti A, Poletti A, Ravanetti C, Novarini A, Parma M. Neuropsychological deficits in arterial hypertension. Acta Neurol Scand. 1986;73:619–27.

    PubMed  CAS  Google Scholar 

  10. Wilkie F, Eisdorfer C. Intelligence and blood pressure in the aged. Science. 1971;172:959–62.

    Article  PubMed  CAS  Google Scholar 

  11. Boller F, Vrtunski PB, Mack JL, Kim Y. Neuropsychological correlates of hypertension. Arch Neurol. 1977;34:701–5.

    PubMed  CAS  Google Scholar 

  12. Franceschi M, Tancredi O, Smirne S, Marcinelli A, Canal N. Cognitive processes in hypertension. Hypertension. 1982;4:226–9.

    PubMed  CAS  Google Scholar 

  13. Shapiro AP, Miller R, King HE, Ginchereau E, Fitzgibbon K. Behavioral consequences of mild hypertension. Hypertension. 1982;4:355–60.

    PubMed  CAS  Google Scholar 

  14. Light KC. Slowing of response time in young and middle-aged hypertensive patients. Exp Aging Res. 1975;1:209–27.

    PubMed  CAS  Google Scholar 

  15. Elias MF, Robbins MA, Schultz NR, Streeter DHP, Elias PK. Clinical significance of cognitive performance by hypertensive patients. Hypertension. 1987;9:192–7.

    PubMed  CAS  Google Scholar 

  16. Wallace RB, Lemke JH, McMorris M, Goodenberger F, Kohout JV, Hinrich S. Relationship of free-recall memory to hypertension in the elderly. The Iowa 65+ Rural Health Study. J Chronic Dis. 1985;38:475–81.

    Article  PubMed  CAS  Google Scholar 

  17. Spieth W. Slowness of task performance and cardiovascular disease. In Welford AT, Birren JE, eds. Behavior, aging and the nervous system. Springfield, IL: Charles C Thomas, 1965.

    Google Scholar 

  18. Miller RE, Shapiro A, King HE, Ginchereau EH, Hosult J. Effect of antihypertensive treatment on the behavioral consequences of elevated blood pressure. Hypertension. 1984;6:202–8.

    PubMed  CAS  Google Scholar 

  19. Lezak M. Neuropsychological assessment. New York: Oxford University Press, 1983; 426.

    Google Scholar 

  20. Wechsler D. Wechsler Adult Intelligence Scale Manual. New York: Psychological Corporation, 1955.

    Google Scholar 

  21. Army Individual Test Battery, Manual of Directions and Scoring. War Department, Adjutant General’s Office, 1944.

  22. Rey A. L’examen clinique en psychologie. Paris: Presses Universi Davis de France, 1964.

    Google Scholar 

  23. Benton AL. The Revised Visual Retention Test (4th ed.). New York: Psychological Corporation, 1974.

    Google Scholar 

  24. Osterrieth PA. Le test de copie d’une figure complexe. Arch Psychol. 1944;30:206–356.

    Google Scholar 

  25. Taylor LB. Localization of cerebral lesions by psychological testing. Clin Neurosurg. 1969;16:269–87.

    PubMed  CAS  Google Scholar 

  26. Beck A. The Beck Depression Inventory. Philadelphia: Center for Cognitive Therapy, 1978.

    Google Scholar 

  27. Spielberger CD, Gorsuch RL, Lushene RE. STAI manual. Palo Alto, CA: Consulting Psychologists Press, 1970.

    Google Scholar 

  28. James M, Griffith DNW, Pearson RM, Newbury P. Effect of oxprenolol on stage fright in musicians. Lancet. 1977;ii:952.

    Article  Google Scholar 

  29. Brantigan CO, Brantigan TA, Joseph N. Effects of beta blockers and beta stimulation on stage fright. Am J Med. 1982;72:88–94.

    Article  PubMed  CAS  Google Scholar 

  30. Taggart P, Carruthers M, Sommerville W. Electrocardiogram, plasma catecholamines and lipids, and their modification by oxprenolol when speaking before an audience. Lancet. 1973;ii:341.

    Article  Google Scholar 

  31. Sharaf A, Salem MB, McDevitt DG. Central effects of beta adrenoreceptor antagonists. Clin Pharmacol Ther. 1983;33:52–7.

    Article  Google Scholar 

  32. Lader MH, Tyrer PJ. Central and peripheral effects of propranolol and sotalol in normal human subjects. Br J Pharmacol. 1972;45:557–60.

    PubMed  CAS  Google Scholar 

  33. Schultz NR, Elias MF, Robbins MA, Streeter DHP, Blakeman N. A longitudinal comparison of hypertensives and normotensives on the Wechsler Adult Intelligence Scale: initial findings. J Gerontol. 1986;41:169–75.

    PubMed  Google Scholar 

  34. Madden DJ, Blumenthal J, Ekelund L, Krantz D, Light K, McKee D. Memory performance by mild hypertensives following betaadrenergic blockade. Psychopharmacology. 1986;89:20–4.

    Article  PubMed  CAS  Google Scholar 

  35. Costa P, Shock NW. New longitudinal data on the question of whether hypertension influences intellectual performance.In Elias MF, Streeter DHP, eds. Hypertension and cognitive processes. Mount Desert, ME: Beech Hill, 1990.

    Google Scholar 

  36. Wood WG, Elias MF, Schultz NR, Pentz CA. Anxiety and depression in young and middle aged hypertensive and normotensive subjects. Exper Aging Res. 1979;5:15–30.

    CAS  Google Scholar 

  37. Goldman H, Kleinman K, Snow M, Bidus D, Korol B. Correlation of diastolic blood pressure and signs of cognitive dysfunction in essential hypertension. Dis Nervous Syst. 1974;35:571–2.

    CAS  Google Scholar 

  38. Waal HJ. Propranolol-induced depression. Br Med J. 1967;2:50.

    Article  PubMed  CAS  Google Scholar 

  39. Petrie WM, Maffucci RJ, Woosley RL. Propranolol and depression. Am J Psychiat. 1982;139:92–4.

    PubMed  CAS  Google Scholar 

  40. Kalayam B, Shamoian C. Propranolol, psychoneuroendocrine change, and depression. Am J Psychiat. 1982;139:1374–5.

    PubMed  CAS  Google Scholar 

  41. Friedman L. How do the various beta blockers compare in type, frequency and severity of their adverse effects? Circulation. 1983;67(suppl I):89–90.

    Google Scholar 

  42. Heine B. Psychogenesis of hypertension. Proc R Soc Med. 1970;63:1267–70.

    PubMed  CAS  Google Scholar 

  43. Wheatley D, Balter M, Levine J, Lipman R, Bauer ML, Bonato R. Psychiatric aspects of hypertension. Br J Psychiat. 1975;127:327–36.

    Article  CAS  Google Scholar 

  44. McNair D. Self-evaluations of antidepressants. Psychopharmacologia. 1974;37:281–302.

    Article  PubMed  CAS  Google Scholar 

  45. Frohlich ED. Beta blockers and mental performance (editorial). Arch Intern Med. 1988;148:777–8.

    Article  PubMed  CAS  Google Scholar 

  46. Gengo FM, Fagan, SC, de Padova A, Miller JK, Kinkel PR. The effect ofβ-blockers on mental performance in older hypertensive patients. Arch Intern Med. 1988;148:779–84.

    Article  PubMed  CAS  Google Scholar 

  47. Machin D, Campbell MJ. Statistical tables for the design of clinical trials. Boston: Blackwell Scientific Publications, 1987.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

Received from the Veterans Administration Medical Center, Portland Division and Oregon Health Sciences University, Portland, Oregon.

Supported by a Veterans Administration Merit Review Grant, Ayerst Laboratories, and Stuart Pharmaceuticals.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Palac, D.M., Cornish, R.D., McDonald, W.J. et al. Cognitive function in hypertensives treated with atenolol or propranolol. J Gen Intern Med 5, 310–318 (1990). https://doi.org/10.1007/BF02600398

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02600398

Key words

Navigation